Abbildung 1: Auftreten von Resistenzmutationen zu Woche 96 in Phase-III-Studien an nichtvorbehandelten Patienten, modifiziert nach (24)
Abb1_35
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.